| CV | Cardiovascular |
| GI | Gastrointestinal |
| IM | intramuscular |
| Opth | Ophthalmic |
| Inj | Injection |
| ADR | Adverse Drug Reaction |
| CNS | Central Nervous System |
| PO | Oral |
| IV | Intravenous |
| Inh | Inhalation |
| Liq | Liquid |
| BB | Black Box Warning |
| SQ | Subcutaneous |
| TD | Transdermal |
| CDAD | Clostridium Difficile Associated Diarrhea |
| GERD | Gastroesophageal Reflux Disease |
| ACEi | Angiotensin-Converting-Enzyme Inhibitor |
| ARB | Angiotensin II Receptor Blockers |
| HMG-CoA Reductase Inhibitor | 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase Inhibitor |
| PPI | Proton Pump Inhibitor |
| CCB | Calcium Channel Blocker |
| SSRI | Selective Serotonin Reuptake Inhibitors |
| SNRI | Serotonin–Norepinephrine Reuptake Inhibitors |
| TCA | Tricyclic Antidepressant |
| NRI | Norepinephrine Reuptake Inhibitor |
| NSAID | Non-Steroidal Anti-Inflammatory Drug |
| SGLT2 Inhibitor | Sodium-Glucose co-Transporter-2 Inhibitor |
| DPP-4 Inhibitor | Dipeptidyl Peptidase-4 Inhibitor |